XML 32 R25.htm IDEA: XBRL DOCUMENT v3.24.3

Revenue (Tables)

9 Months Ended

Sep. 30, 2024

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregated Revenue

The following table presents our disaggregated revenue for the periods presented (in thousands):

		Three Months Ended September 30,								Nine Months Ended September 30,
		2024				2023				2024				2023
MRD revenue
Service revenue		$	32,470			$	24,668			$	92,880			$	71,977
Regulatory milestone revenue			5,000				—				12,500				—
Total MRD revenue			37,470				24,668				105,380				71,977
Immune Medicine revenue
Service revenue			5,453				5,238				16,160				17,848
Collaboration revenue			3,512				8,013				9,958				34,667
Total Immune Medicine revenue			8,965				13,251				26,118				52,515
Total revenue		$	46,435			$	37,919			$	131,498			$	124,492

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-5

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration